keyword
MENU ▼
Read by QxMD icon Read
search

schizophrenia and smoking cessation

keyword
https://www.readbyqxmd.com/read/28314679/an-analysis-of-the-rewarding-and-aversive-associative-properties-of-nicotine-in-the-neonatal-quinpirole-model-effects-on-glial-cell-line-derived-neurotrophic-factor-gdnf
#1
Russell W Brown, Seth L Kirby, Adam R Denton, John M Dose, Elizabeth D Cummins, Wesley Drew Gill, Katherine C Burgess
This study analyzed the associative properties of nicotine in a conditioned place preference (CPP) paradigm in adolescent rats neonatally treated with quinpirole (NQ) or saline (NS). NQ produces dopamine D2 receptor supersensitivity that persists throughout the animal's lifetime, and therefore has relevance towards schizophrenia. In two experiments, rats were ip administered quinpirole (1mg/kg) or saline from postnatal day (P)1-21. After an initial preference test at P42-43, animals were conditioned for eight consecutive days with saline or nicotine (0...
March 14, 2017: Schizophrenia Research
https://www.readbyqxmd.com/read/28285208/predictors-of-tobacco-abstinence-in-outpatient-smokers-with-schizophrenia-or-bipolar-disorder-treated-with-varenicline-and-cognitive-behavioral-smoking-cessation-therapy
#2
Randi M Schuster, Corinne Cather, Gladys N Pachas, Haiyue Zhang, Kristina M Cieslak, Susanne S Hoeppner, David Schoenfeld, A Eden Evins
BACKGROUND: The estimated mortality gap between those with and without serious mental illness (SMI) is increasing, now estimated at 28years, which is largely due to smoking-related diseases. AIMS: We sought to identify predictors of 14-day continuous abstinence in stable outpatient smokers with SMI. METHOD: Adult smokers with schizophrenia spectrum (n=130) or bipolar disorder (n=23) were enrolled in a 12-week course of varenicline and cognitive-behavioral therapy for smoking cessation...
February 24, 2017: Addictive Behaviors
https://www.readbyqxmd.com/read/28270120/long-term-effects-of-smoking-cessation-in-hospitalized-schizophrenia-patients
#3
Masatoshi Miyauchi, Ikuko Kishida, Akira Suda, Yohko Shiraishi, Mami Fujibayashi, Masataka Taguri, Chie Ishii, Norio Ishii, Toshio Moritani, Yoshio Hirayasu
BACKGROUND: The prevalence of smoking in patients with schizophrenia is higher than that in the general population and is an important medical issue. Short-term smoking cessation tends to worsen psychiatric symptoms in patients with schizophrenia but decreases sympathetic nervous system activity and improves plasma cholesterol levels in healthy people. Few studies have assessed the long-term effects of smoking cessation in patients with schizophrenia. METHODS: Subjects were 70 Japanese patients with schizophrenia (38 smokers, 32 non-smokers)...
March 7, 2017: BMC Psychiatry
https://www.readbyqxmd.com/read/28258047/mobile-phone-apps-for-smoking-cessation-quality-and-usability-among-smokers-with-psychosis
#4
Joelle C Ferron, Mary F Brunette, Pamela Geiger, Lisa A Marsch, Anna M Adachi-Mejia, Stephen J Bartels
BACKGROUND: Smoking is one of the top preventable causes of mortality in people with psychotic disorders such as schizophrenia. Cessation treatment improves abstinence outcomes, but access is a barrier. Mobile phone apps are one way to increase access to cessation treatment; however, whether they are usable by people with psychotic disorders, who often have special learning needs, is not known. OBJECTIVE: Researchers reviewed 100 randomly selected apps for smoking cessation to rate them based on US guidelines for nicotine addiction treatment and to categorize them based on app functions...
March 3, 2017: JMIR Human Factors
https://www.readbyqxmd.com/read/28238173/chronic-low-grade-peripheral-inflammation-is-associated-with-severe-nicotine-dependence-in-schizophrenia-results-from-the-national-multicentric-face-sz-cohort
#5
G Fond, F Berna, M Andrianarisoa, O Godin, M Leboyer, L Brunel, B Aouizerate, D Capdevielle, I Chereau, T D'Amato, H Denizot, C Dubertret, J Dubreucq, C Faget, F Gabayet, P M Llorca, J Mallet, D Misdrahi, C Passerieux, R Richieri, R Rey, A Schandrin, M Urbach, P Vidailhet, L Boyer, F Schürhoff
Chronic peripheral inflammation (CPI) has been associated with cognitive impairment in schizophrenia (SZ). However, its sources remain unclear, more specifically it is not known whether tobacco smoking is a source of inflammation or not in SZ subjects. Moreover, nicotine (NIC), the major psychoactive compound of tobacco, shows strong anti-inflammatory properties in vitro, as well as inducing a severe biological dependence when administered repeatedly. The objective of the present study was to determine if CPI was associated with tobacco smoking and/or NIC dependence in schizophrenia...
February 25, 2017: European Archives of Psychiatry and Clinical Neuroscience
https://www.readbyqxmd.com/read/28126031/smoking-cessation-intervention-for-severe-mental-ill-health-trial-scimitar-study-protocol-for-a-randomised-controlled-trial
#6
Emily Peckham, Catherine Arundel, Della Bailey, Stuart Brownings, Caroline Fairhurst, Paul Heron, Jinshuo Li, Steve Parrott, Simon Gilbody
BACKGROUND: Smoking is highly prevalent among people who have experience of severe mental ill health, contributing to their poor physical health. Despite the 'culture' of smoking in mental health services, people with severe mental ill health often express a desire to quit smoking; however, the services currently available to aid quitting are those which are widely available to the general population and may not be suitable or effective for people with severe mental ill health. The aim of this study is to explore the effectiveness and cost-effectiveness of a bespoke smoking-cessation intervention specifically targeted at people with severe mental ill health...
January 26, 2017: Trials
https://www.readbyqxmd.com/read/28104060/comparison-of-suicide-attempts-behaviors-following-smoking-cessation-treatments-among-schizophrenic-smokers
#7
I-Hsuan Wu, Hua Chen, Patrick Bordnick, Ekere James Essien, Michael Johnson, Ronald J Peters, Xin Wang, Susan M Abughosh
BACKGROUND: Smoking cessation may lead to depression in some smokers and result in increased risk of suicide. OBJECTIVE: To compare the risk of suicide attempts/behaviors associated with different smoking cessation medications among schizophrenic patients. METHODS: A retrospective cohort study was conducted using General Electric (GE) medical record database (1995-2011). The first day of being prescribed a smoking cessation medication defined as index date...
February 2017: Archives of Psychiatric Nursing
https://www.readbyqxmd.com/read/27995279/from-bench-to-bedside-mglur2-positive-allosteric-modulators-as-medications-to-treat-substance-use-disorders
#8
REVIEW
Jane B Acri, Alan J Cross, Phil Skolnick
OBJECTIVE: This paper provides an overview of the role of type 2 metabotropic glutamate receptors (mGluR2) in addiction and behaviors reflecting addictive processes. RESULTS: AZD8529, an mGluR2 positive allosteric modulator (PAM), failed to separate from placebo in a phase II schizophrenia trial. The demonstration by Athina Markou's laboratory that AZD8529 attenuated both nicotine self-administration and cue-induced reinstatement was a key factor in the decision to move this compound into a smoking cessation study...
December 20, 2016: Psychopharmacology
https://www.readbyqxmd.com/read/27969002/smoking-cessation-programs-for-persons-with-schizophrenia-an-urgent-unmet-need
#9
María Paz García-Portilla, Julio Bobes
No abstract text is available yet for this article.
October 2016: Revista de Psiquiatrí́a y Salud Mental
https://www.readbyqxmd.com/read/27901521/electronic-cigarette-use-in-patients-with-schizophrenia-prevalence-and-attitudes
#10
Brian J Miller, Alexandre Wang, Joyce Wong, Nina Paletta, Peter F Buckley
BACKGROUND: Smoking is highly prevalent in patients with schizophrenia. Electronic cigarettes (e-cigarettes) are becoming increasingly popular among smokers. Surveys indicate overall favorable attitudes toward the use of e-cigarettes to reduce or quit smoking, relieve withdrawal symptoms, and with respect to perceived health risks; however, less is known about their use in patients with schizophrenia. In the present study, we investigated the prevalence of and attitudes toward e-cigarettes in patients with schizophrenia...
February 2017: Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists
https://www.readbyqxmd.com/read/27708591/cognitive-dysfunction-affective-states-and-vulnerability-to-nicotine-addiction-a-multifactorial-perspective
#11
Morgane Besson, Benoît Forget
Although smoking prevalence has declined in recent years, certain subpopulations continue to smoke at disproportionately high rates and show resistance to cessation treatments. Individuals showing cognitive and affective impairments, including emotional distress and deficits in attention, memory, and inhibitory control, particularly in the context of psychiatric conditions, such as attention-deficit hyperactivity disorder, schizophrenia, and mood disorders, are at higher risk for tobacco addiction. Nicotine has been shown to improve cognitive and emotional processing in some conditions, including during tobacco abstinence...
2016: Frontiers in Psychiatry
https://www.readbyqxmd.com/read/27613888/combination-extended-smoking-cessation-treatment-plus-home-visits-for-smokers-with-schizophrenia-a-randomized-controlled-trial
#12
Arthur L Brody, Todd Zorick, Robert Hubert, Gerhard S Hellemann, Shabnam Balali, Sarah S Kawasaki, Lizette Y Garcia, Ryutaro Enoki, Paul Abraham, Paulina Young, Charles McCreary
INTRODUCTION: The majority of people with schizophrenia have a diagnosis of tobacco dependence during their lifetime. A major obstacle to reducing the burden of cigarette smoking in this population is that these smokers have lower quit rates when undergoing standard treatment compared to smokers with no mental illness. We sought to determine if combination extended treatment (COMB-EXT) and home visits (HV) would lead to improved outcomes in smokers with schizophrenia. METHODS: Thirty-four cigarette smokers with schizophrenia completed either COMB-EXT with HV, COMB-EXT without HV, or treatment as usual (TAU) (random assignment)...
January 2017: Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco
https://www.readbyqxmd.com/read/27391334/smokers-with-self-reported-mental-health-conditions-a-case-for-screening-in-the-context-of-tobacco-cessation-services
#13
Gary J Tedeschi, Sharon E Cummins, Christopher M Anderson, Robert M Anthenelli, Yue-Lin Zhuang, Shu-Hong Zhu
BACKGROUND: People with mental health conditions (MHC) smoke at high rates and many die prematurely from smoking-related illnesses. Smoking cessation programs, however, generally do not screen for MHC. This study examined the utility of MHC screening in a large tobacco quitline to determine whether self-reported MHC predicts service utilization and quitting behaviors. METHODS & FINDINGS: A brief set of question on MHC was embedded in the routine intake of a state quitline, and 125,261 smokers calling from June 2012 to September 2015 were asked the questions...
2016: PloS One
https://www.readbyqxmd.com/read/27005897/increased-ventro-medial-prefrontal-activations-in-schizophrenia-smokers-during-cigarette-cravings
#14
Stéphane Potvin, Ovidiu Lungu, Olivier Lipp, Pierre Lalonde, Vessela Zaharieva, Emmanuel Stip, Jean-Pierre Melun, Adrianna Mendrek
BACKGROUND: Highly prevalent in schizophrenia, tobacco smoking substantially increases the risk of cardiac-related death. Compared to the general population, tobacco smoking cessation rates are lower in schizophrenia. Unfortunately, the reasons for these low cessation rates remain poorly understood. Recently, it has been shown that tobacco cravings are increased in schizophrenia smokers compared to smokers with no comorbid psychiatric disorder. In view of these results, we sought to examine - for the first time - the neurophysiologic responses elicited by cigarette cues in schizophrenia smokers...
May 2016: Schizophrenia Research
https://www.readbyqxmd.com/read/26824336/smoking-reduction-and-quality-of-life-in-chronic-patients-with-schizophrenia-in-a-chinese-population-a-pilot-study
#15
Huiqiong Deng, Jia Wang, Xiangyang Zhang, Mengying Ma, Coreen Domingo, Hongqiang Sun, Thomas Kosten
BACKGROUND AND OBJECTIVES: Tobacco use is a significant public health issue on a global scale. Prevalence of daily tobacco smoking for men in China is much higher than in the United States. Although prevailing literature suggests a negative relationship between smoking and quality of life, this pilot study sought to evaluate whether smoking reduction/cessation impacted on the perception of quality of life in an in-patient population in China. METHODS: Twenty Chinese patients meeting DSM-IV criteria for schizophrenia were recruited from Beijing Hui-Long-Guan Hospital, an in-patient facility in Beijing, China, for participation in this 4-week study...
March 2016: American Journal on Addictions
https://www.readbyqxmd.com/read/26816385/smoking-cessation-advice-for-people-with-serious-mental-illness
#16
REVIEW
Priya Khanna, Andrew V Clifton, David Banks, Graeme E Tosh
BACKGROUND: People with a serious mental illness are more likely to smoke more and to be more dependent smokers than the general population. This may be due to a wide range of factors that could include a common aetiology to both smoking and the illness, self medication, smoking to alleviate adverse effects of medications, boredom in the existing environment, or a combination of these factors. It is important to undertake this review to facilitate improvements in both the health and safety of people with serious mental illness who smoke, and to reduce the overall burden of costs (both financial and health) to the smoker and, eventually, to the taxpayer...
2016: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/26803692/nachr-dysfunction-as-a-common-substrate-for-schizophrenia-and-comorbid-nicotine-addiction-current-trends-and-perspectives
#17
REVIEW
Vinay Parikh, Munir Gunes Kutlu, Thomas J Gould
INTRODUCTION: The prevalence of tobacco use in the population with schizophrenia is enormously high. Moreover, nicotine dependence is found to be associated with symptom severity and poor outcome in patients with schizophrenia. The neurobiological mechanisms that explain schizophrenia-nicotine dependence comorbidity are not known. This study systematically reviews the evidence highlighting the contribution of nicotinic acetylcholine receptors (nAChRs) to nicotine abuse in schizophrenia...
March 2016: Schizophrenia Research
https://www.readbyqxmd.com/read/26612616/effects-of-the-nicotinic-agonist-varenicline-on-the-performance-of-tasks-of-cognition-in-aged-and-middle-aged-rhesus-and-pigtail-monkeys
#18
Alvin V Terry, Marc Plagenhoef, Patrick M Callahan
RATIONALE: Due to the rising costs of drug development especially in the field of neuropsychiatry, there is increasing interest in efforts to identify new clinical uses for existing approved drugs (i.e., drug repurposing). OBJECTIVES: The purpose of this work was to evaluate in animals the smoking cessation agent, varenicline, a partial agonist at α4β2 and full agonist at α7 nicotinic acetylcholine receptors, for its potential as a repurposed drug for disorders of cognition...
March 2016: Psychopharmacology
https://www.readbyqxmd.com/read/26607103/mortality-in-schizophrenia-and-bipolar-disorder-clinical-and-serological-predictors
#19
Faith Dickerson, Andrea Origoni, Jennifer Schroeder, Lucy A B Schweinfurth, Cassie Stallings, Christina L G Savage, Emily Katsafanas, Maria Banis, Sunil Khushalani, Robert Yolken
Persons with schizophrenia and with bipolar disorder have a reduced life expectancy due largely to death from natural causes. The reasons for this increased mortality have not been completely defined. We prospectively assessed a cohort of persons with schizophrenia and one with bipolar disorder with a clinical evaluation and a blood sample from which immune and infectious disease markers were measured. Mortality was determined with data from the National Death Index following a period of up to 14years. We examined the role of demographic, clinical, and serological factors on mortality in bivariate and multivariate models...
January 2016: Schizophrenia Research
https://www.readbyqxmd.com/read/26594837/efficacy-and-tolerability-of-pharmacotherapy-for-smoking-cessation-in-adults-with-serious-mental-illness-a-systematic-review-and-network-meta-analysis
#20
REVIEW
Emmert Roberts, A Eden Evins, Ann McNeill, Debbie Robson
BACKGROUND AND AIMS: To assess the efficacy and tolerability of adjunctive pharmacotherapy for smoking cessation in adults with serious mental illness (SMI) by means of a systematic review and network meta-analysis. METHOD: We searched Embase, Medline, PsychINFO and the Cochrane Central Register of Controlled Trials from database inception to 1 December 2014 for randomized controlled trials (RCTs) published in English. We included all studies of smokers with SMI (including schizophrenia, schizoaffective disorder, bipolar disorder, delusional disorder and depressive psychoses) who were motivated to quit smoking...
April 2016: Addiction
keyword
keyword
74279
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"